These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 839445)

  • 1. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.
    Rane A; Wilkinson GR; Shand DG
    J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
    Fenyves D; Gariépy L; Villeneuve JP
    Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of carbamazepine and its 10,11-epoxide metabolite in the isolated perfused rat liver.
    Rane A; Shand DG; Wilkinson GR
    Drug Metab Dispos; 1977; 5(2):179-84. PubMed ID: 15811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. II. Kinetics of steady state elimination.
    Saville BA; Gray MR; Tam YK
    Drug Metab Dispos; 1987; 15(1):17-21. PubMed ID: 2881753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
    Callaghan R; Desmond PV; Paull P; Mashford ML
    Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
    Shrewsbury RP
    Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiological principles of imipramine pharmacokinetics].
    Szymura-Oleksiak J
    Folia Med Cracov; 1989; 30(3-4):103-21. PubMed ID: 2641936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of 5-hydroxytryptamine by rat lung and liver: the importance of relative perfusion and intrinsic clearance.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1980 Jan; 212(1):97-102. PubMed ID: 7351629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.
    Shibata Y; Takahashi H; Ishii Y
    Drug Metab Dispos; 2000 Dec; 28(12):1518-23. PubMed ID: 11095592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition kinetics of propranolol isomers in the perfused rat liver.
    Hung DY; Siebert GA; Chang P; Anissimov YG; Roberts MS
    J Pharmacol Exp Ther; 2004 Nov; 311(2):822-9. PubMed ID: 15192084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
    Egfjord M
    Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diffusional barriers on drug and metabolite kinetics.
    de Lannoy IA; Pang KS
    Drug Metab Dispos; 1987; 15(1):51-8. PubMed ID: 2881759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
    Siebert GA; Hung DY; Chang P; Roberts MS
    J Pharmacol Exp Ther; 2004 Jan; 308(1):228-35. PubMed ID: 14566005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1985 May; 233(2):277-84. PubMed ID: 3999018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes.
    Singh K; Tripp SL; Dunton AW; Douglas FL; Rakhit A
    Drug Metab Dispos; 1991; 19(5):990-6. PubMed ID: 1686248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic model for N-nitrosodimethylamine based on Michaelis-Menten constants determined with the isolated perfused rat liver.
    Skipper PL; Tomera JF; Wishnok JS; Brunengraber H; Tannenbaum SR
    Cancer Res; 1983 Oct; 43(10):4786-90. PubMed ID: 6883335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.